Zhengye Financial Statements From 2010 to 2026

ZYBT Stock   1.15  0.01  0.88%   
Analyzing historical trends in various income statement and balance sheet accounts from Zhengye Biotechnology's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Zhengye Biotechnology's valuation are summarized below:
Gross Profit
57.5 M
Profit Margin
(0.13)
Market Capitalization
54.5 M
Enterprise Value Revenue
2.7289
Revenue
153.7 M
There are currently one hundred twenty fundamental gauges for Zhengye Biotechnology that can be evaluated and compared over time across peers. All traders should confirm Zhengye Biotechnology's prevalent fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction.

Zhengye Biotechnology Total Revenue

169.39 Million

Check Zhengye Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zhengye Biotechnology's main balance sheet or income statement drivers, such as Tax Provision of 790 K, Interest Income of 211.5 K or Depreciation And Amortization of 22.8 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.0. Zhengye financial statements analysis is a perfect complement when working with Zhengye Biotechnology Valuation or Volatility modules.
  
Build AI portfolio with Zhengye Stock
Check out the analysis of Zhengye Biotechnology Correlation against competitors.

Zhengye Biotechnology Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets539.3 M567.2 M468.4 M
Slightly volatile
Short and Long Term Debt Total74.6 M99.4 M45.6 M
Slightly volatile
Other Current Liabilities5.6 M5.6 M6.9 M
Very volatile
Total Current Liabilities154 M156.3 M132.7 M
Slightly volatile
Total Stockholder Equity309 M326.6 M276.4 M
Slightly volatile
Property Plant And Equipment Net211.3 M229.6 M253.7 M
Slightly volatile
Current Deferred Revenue3.3 M3.3 M4.1 M
Slightly volatile
Net Debt63.6 M78 M36.7 M
Slightly volatile
Retained Earnings38.8 M43.3 M43.7 M
Pretty Stable
Accounts Payable46.1 M38.7 M69.6 M
Slightly volatile
Cash15 M21.4 M9.1 M
Slightly volatile
Non Current Assets Total332.5 M363 M292.6 M
Slightly volatile
Non Currrent Assets Other32.3 M30.8 M15.1 M
Slightly volatile
Cash And Short Term Investments14.4 M23 M9.3 M
Slightly volatile
Net Receivables77.4 M88.5 M99.1 M
Slightly volatile
Common Stock Shares Outstanding37.7 M42.4 M46.3 M
Slightly volatile
Liabilities And Stockholders Equity538.5 M567.2 M468.3 M
Slightly volatile
Non Current Liabilities Total6.9 M5.5 M2.8 M
Slightly volatile
Inventory60.2 M67 M48.4 M
Slightly volatile
Other Current Assets19.3 M12.4 M14.3 M
Slightly volatile
Other Stockholder Equity162.5 M182.8 M199.6 M
Slightly volatile
Total Liabilities160.9 M161.8 M135.5 M
Slightly volatile
Net Invested Capital382.8 M426 M321.9 M
Slightly volatile
Property Plant And Equipment Gross398.1 M421.7 M360.2 M
Slightly volatile
Short and Long Term Debt67.8 M93.9 M43.4 M
Slightly volatile
Total Current Assets150.4 M159.8 M169.8 M
Pretty Stable
Accumulated Other Comprehensive Income31.2 M37.5 M25 M
Slightly volatile
Capital Stock6.4 K7.2 K7.9 K
Slightly volatile
Net Working Capital54.6 M47.9 M43.1 M
Slightly volatile
Short Term Debt67.8 M93.9 M43.4 M
Slightly volatile
Intangible Assets20.5 M26.2 M14.7 M
Slightly volatile
Common Stock6.4 K7.2 K7.9 K
Slightly volatile
Long Term Debt6.6 M4.3 M9.2 M
Slightly volatile

Zhengye Biotechnology Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Tax Provision790 K831.6 K5.7 M
Slightly volatile
Interest Income211.5 K265.6 K145.8 K
Slightly volatile
Depreciation And Amortization22.8 M27.8 M18.2 M
Slightly volatile
Interest Expense3.6 M4.6 M1.9 M
Slightly volatile
Selling General Administrative36 M22.6 M26.2 M
Slightly volatile
Selling And Marketing Expenses41.9 M47.5 M37.5 M
Slightly volatile
Total Revenue169.4 M167.7 M209.7 M
Slightly volatile
Gross Profit94.6 M82.2 M121 M
Slightly volatile
Other Operating Expenses138.5 M152.9 M162.5 M
Very volatile
Operating Income31.5 M16.4 M47.3 M
Slightly volatile
Net Income From Continuing Ops11.5 M12.1 M40.5 M
Slightly volatile
EBIT32.7 M18.4 M49 M
Slightly volatile
Research Development13.7 M14.7 M11.9 M
Slightly volatile
EBITDA54.1 M38.3 M66.7 M
Slightly volatile
Cost Of Revenue102.8 M109.3 M91.8 M
Slightly volatile
Total Operating Expenses107.7 M74.9 M82.4 M
Slightly volatile
Reconciled Depreciation22.8 M27.8 M18.2 M
Slightly volatile
Income Before Tax12.3 M13 M46.1 M
Slightly volatile
Net Income9.7 M10.2 M33.9 M
Slightly volatile
Income Tax Expense790 K831.6 K5.7 M
Slightly volatile

Zhengye Biotechnology Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow16.3 M31.3 MM
Slightly volatile
Depreciation23.6 M27.8 M18.3 M
Slightly volatile
Other Non Cash Items4.8 M3.1 M4.1 M
Slightly volatile
Capital Expenditures26.6 M31.9 M26 M
Very volatile
Total Cash From Operating Activities39.5 M47.2 M33.8 M
Slightly volatile
Net Income26.3 M13.5 M41.3 M
Slightly volatile
End Period Cash Flow17.7 M21.4 M10 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Days Sales Outstanding195199178
Slightly volatile
Capex To Depreciation1.31.321.4995
Slightly volatile
EV To Sales0.210.330.1646
Slightly volatile
ROIC0.03830.04030.1126
Slightly volatile
Inventory Turnover1.931.881.9509
Slightly volatile
Days Of Inventory On Hand171201188
Slightly volatile
Payables Turnover1.31.991.3153
Slightly volatile
Sales General And Administrative To Revenue0.0880.110.106
Pretty Stable
Research And Ddevelopement To Revenue0.04590.06180.0542
Slightly volatile
Capex To Revenue0.0880.130.118
Slightly volatile
Interest Coverage4.444.6838.0881
Slightly volatile
Payout Ratio0.681.270.4989
Slightly volatile
Capex To Operating Cash Flow0.910.780.832
Very volatile
Days Payables Outstanding264190290
Slightly volatile
Income Quality2.882.741.0869
Slightly volatile
ROE0.04350.04580.1265
Slightly volatile
EV To Operating Cash Flow1.421.491.0731
Slightly volatile
Return On Tangible Assets0.02630.02760.0774
Slightly volatile
Intangibles To Total Assets0.02860.04160.0301
Slightly volatile
Net Debt To EBITDA0.721.430.5578
Slightly volatile
Current Ratio1.491.51.3429
Slightly volatile
Receivables Turnover1.661.892.0507
Slightly volatile
Debt To Equity0.190.270.1564
Slightly volatile
Debt To Assets0.110.160.0917
Slightly volatile
Enterprise Value Over EBITDA0.721.430.5578
Slightly volatile
Short Term Coverage Ratios0.680.580.9062
Slightly volatile
Operating Cycle312357360
Pretty Stable
Days Of Payables Outstanding264190290
Slightly volatile
Dividend Payout Ratio0.681.270.4989
Slightly volatile
Pretax Profit Margin0.08440.08880.2163
Slightly volatile
Ebt Per Ebit1.061.011.0027
Slightly volatile
Operating Profit Margin0.09640.10.2169
Slightly volatile
Effective Tax Rate0.120.07380.1189
Slightly volatile
Company Equity Multiplier1.41.561.6623
Pretty Stable
Long Term Debt To Capitalization0.0310.01910.0309
Slightly volatile
Total Debt To Capitalization0.150.210.1312
Slightly volatile
Return On Capital Employed0.05030.05290.1426
Slightly volatile
Debt Equity Ratio0.190.270.1564
Slightly volatile
Ebit Per Revenue0.09640.10.2169
Slightly volatile
Quick Ratio1.071.010.9748
Slightly volatile
Dividend Paid And Capex Coverage Ratio0.620.840.817
Pretty Stable
Net Income Per E B T0.590.710.7262
Slightly volatile
Cash Ratio0.07020.120.0642
Slightly volatile
Cash Conversion Cycle12020977.043
Slightly volatile
Operating Cash Flow Sales Ratio0.140.20.1551
Slightly volatile
Days Of Inventory Outstanding171201188
Slightly volatile
Days Of Sales Outstanding195199178
Slightly volatile
Cash Flow Coverage Ratios0.640.550.8936
Slightly volatile
Fixed Asset Turnover0.90.840.8374
Very volatile
Capital Expenditure Coverage Ratio1.51.331.3856
Slightly volatile
Enterprise Value Multiple0.721.430.5578
Slightly volatile
Debt Ratio0.110.160.0917
Slightly volatile
Cash Flow To Debt Ratio0.640.550.8936
Slightly volatile
Return On Assets0.02510.02640.0751
Slightly volatile
Asset Turnover0.50.430.4706
Slightly volatile
Net Profit Margin0.06630.06980.1593
Slightly volatile
Gross Profit Margin0.630.560.5831
Pretty Stable
Return On Equity0.04350.04580.1265
Slightly volatile

Zhengye Fundamental Market Drivers

About Zhengye Biotechnology Financial Statements

Zhengye Biotechnology shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Zhengye Biotechnology investors may analyze each financial statement separately, they are all interrelated. The changes in Zhengye Biotechnology's assets and liabilities, for example, are also reflected in the revenues and expenses on on Zhengye Biotechnology's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue3.3 M3.3 M
Total Revenue167.7 M169.4 M
Cost Of Revenue109.3 M102.8 M
Sales General And Administrative To Revenue 0.11  0.09 
Research And Ddevelopement To Revenue 0.06  0.05 
Capex To Revenue 0.13  0.09 
Ebit Per Revenue 0.10  0.10 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Zhengye Stock Analysis

When running Zhengye Biotechnology's price analysis, check to measure Zhengye Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zhengye Biotechnology is operating at the current time. Most of Zhengye Biotechnology's value examination focuses on studying past and present price action to predict the probability of Zhengye Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zhengye Biotechnology's price. Additionally, you may evaluate how the addition of Zhengye Biotechnology to your portfolios can decrease your overall portfolio volatility.